COMP <GO>
IMMP vs SHPH // REVENUE GROWTH (YOY)
Immutep Limited (NASDAQ) VS. Shuttle Pharmaceuticals Holdings Inc. (NASDAQ) • 15-METRIC TALLY: IMMP 0
— SHPH 2
■ METRIC PARITY
LAST: $3.33 (+0.30%) • MKT CAP: $24.5M
revenue-growth
—
LAST: $5.23 (-0.19%) • MKT CAP: $24.9M
revenue-growth
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMMP VS. SHPH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMMP | SHPH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 1/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 23.1 | 58.0 | -34.86 | SHPH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $24.5M | $24.9M | -$375.4K | SHPH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMMP REV | SHPH REV | IMMP GROSS % | SHPH GROSS % | IMMP FCF | SHPH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $0 | — | — | — | -$9.5M |
| FY 2024 | — | $0 | — | — | — | -$7.3M |
| FY 2023 | — | $0 | — | — | — | -$5.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMMP // BETA —
SHPH // BETA —